Paget disease of bone — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Give intravenous zoledronic acid
Explanation lettering: D = shown as A · A = shown as B · B = shown as C · C = shown as D
Give intravenous zoledronic acid is best because symptomatic active Paget disease is treated effectively with bisphosphonate therapy, often intravenous zoledronic acid. A is less suitable because hydroxychloroquine is used in SLE/RA and not Paget disease; B is less suitable because rituximab has no role in Paget disease; D is less suitable because prednisolone is not Paget therapy; E is less suitable because methotrexate treats inflammatory arthritis. Clinical pearl: Paget treatment aims to suppress high bone turnover and improve bone pain.
Reference: Endocrine Society Paget guideline; BNF